Saltar al contenido
Dispositivos y mediciónEstudio transversal3 min read

US wearable use reached 36.36% in 2022, but only 26.5% of users had shared data with providers

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Usage Trends and Data Sharing Practices of Healthcare Wearable Devices Among US Adults: Cross-Sectional Study. · Journal of medical Internet research · 2025 · Artículo original ↗

Idea principal

In a 2022 survey of 5591 US adults, 36.36% (2033) used a wearable, and 78.4% of users (1584 of 2020) were open to sharing data with providers but only 26.5% (535 of 2020) had done so. This is a self-reported national survey at one point in time, so it describes patterns, not what drives them.

Study design

Estudio transversal

Reading basis

Published abstract

Reading focus

Association & confounding

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Wearables promise continuous monitoring, but their use and the sharing of their data with clinicians depend on who people are and how they feel about technology. The authors examined how many US adults used wearables in the later phase of COVID-19, and who is willing to share data and who actually does.

Población y método

Cross-sectional analysis of the National Cancer Institute's Health Information National Trends Survey 6, conducted from March to November 2022, using responses from 5591 US adults. The analysis covered wearable use, willingness to share wearable data with providers, family and friends, and actual sharing behavior, with odds ratios (OR) for associated factors.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Wearable use was 36.36% (2033 of 5591) in 2022, up from 28%-30% in 2019.
  2. 2
    78.4% of users (1584 of 2020) were willing to share data with health care providers, but only 26.5% (535 of 2020) had done so.
  3. 3
    Wearable use was more likely among women (OR 1.49, 95% CI 1.17-1.90, P<.01) and people with higher incomes (OR 2.65, 95% CI 1.42-4.93 for US $50,000 to $75,000; OR 3.2, 95% CI 1.71-5.97 above $75,000). Use and sharing declined with age.
  4. 4
    Hispanic respondents were more willing than African American respondents to share with providers (OR 1.92, 95% CI 1.02-3.62) but less likely to actually share (OR 0.44, 95% CI 0.20-0.97). Provider visit frequency (OR 1.23) and number of medical conditions (OR 1.35) predicted sharing.

Límites e incertidumbre

  1. 1
    Everything is self-reported in a one-time survey, so it cannot show why people do or do not share data.
  2. 2
    The 2019 comparison figure (28%-30%) comes from earlier surveys, and the abstract does not say whether the wording or methods were identical, so the rise should be read cautiously.
  3. 3
    Several confidence intervals are wide (for example OR 1.02-3.62), and the Hispanic versus African American comparison involves a smaller subgroup. Results apply to the US only. This reading is based on the abstract only.

Relevancia práctica

Wearables are now common in the US, but most users who would be willing to share the data with their clinician have not done so. If you use a device, consider asking your clinician whether a trend summary would be useful; it does not need to be a data dump. Privacy settings are worth reviewing before sharing.

Tus datos

The practical step is to prepare a short summary from one device, such as resting heart rate, sleep duration or weekly activity trend over several weeks, rather than single days. Check how your device's app lets you export or share data.

Cómo interpretar la evidencia

Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Health care wearable devices can transform health care delivery by enabling real-time, continuous monitoring that facilitates early disease detection, personalized treatments, and improved patient engagement. The COVID-19 pandemic has heightened awareness of the importance of health technology, accelerating interest in wearables as tools for monitoring health and managing chronic conditions. As we navigate the postpandemic era, understanding the adoption and data-sharing behaviors associated with wearable devices has become increasingly critical. Despite their potential, challenges and low adoption rates persist, with significant gaps in understanding the impact of sociodemographic factors, health conditions, and digital literacy on the use and data-sharing behaviors of these devices.

Objective

This study aimed to explore the usage and data-sharing practices (willingness to share wearable data and actual data-sharing behavior) of wearable devices among US adults specifically during the later phases of the COVID-19 pandemic.

Methods

Using cross-sectional data from the National Cancer Institute's Health Information National Trends Survey 6, conducted from March to November 2022, this study uses responses from 5591 US adults to examine wearable use, willingness to share wearable data with providers, family, and friends, and the wearable data-sharing behavior.

Results

The results indicate an increase in wearable device adoption to 36.36% (2033/5591) in 2022, up from 28%-30% in 2019. We also find a significant discrepancy between the willingness to share data, with 78.4% (1584/2020) of users open to sharing with health care providers, and the actual sharing behavior, where only 26.5% (535/ 2020) have done so. Higher odds of using wearables were associated with female gender (odds ratio [OR] 1.49, 95% CI 1.17-1.90, P<.01) and higher income levels (OR 2.65, 95% CI 1.42-4.93, P<.01 for incomes between US $50,000 and US $75,000, and OR 3.2, 95% CI 1.71-5.97, P<.01 for incomes above US $75,000). However, the likelihood of usage and data sharing declines significantly with age. Compared with African American respondents, Hispanic respondents were more willing to share wearable data with providers (OR 1.92, 95% CI 1.02-3.62, P<.05), though the odds of their actual sharing of wearable data with providers was relatively less (OR 0.44, 95% CI 0.20-0.97, P<.05). Frequency of provider visits (OR 1.23, 95% CI 1.08-1.39, P<.01), and total medical conditions (OR 1.35, 95% CI 1.05-1.73, P<.01) were significant predictors of data-sharing behavior. The study also identified weight, frequency of provider visits, technological self-efficacy and frequent physical activity as predictors for higher wearable use.

Conclusions

Insights from this study are crucial for health care providers and policy makers aiming to leverage wearable technology to enhance health outcomes. Addressing the disparities and barriers identified can lead to more effective integration of these technologies in health care systems, thereby maximizing the potential of digital health tools to improve public health outcomes.

Fuentes y atribución

Usage Trends and Data Sharing Practices of Healthcare Wearable Devices Among US Adults: Cross-Sectional Study.

Chandrasekaran R, Sadiq T M, Moustakas E.

Journal of medical Internet research · 2025-02-21

DOI: 10.2196/63879 ↗PubMed · 39982763 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →